DNUT Fundamental Analysis - KRISPY KREME INC

Fundamental Rating

DNUT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 134 industry peers in the Hotels, Restaurants & Leisure industry. DNUT may be in some trouble as it scores bad on both profitability and health. DNUT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

DNUT had negative earnings in the past year.

In the past year DNUT has reported a negative cash flow from operations.

In the past 5 years DNUT reported 4 times negative net income.

In the past 5 years DNUT always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of -17.16%, DNUT is doing worse than 89.55% of the companies in the same industry.

Looking at the Return On Equity, with a value of -65.09%, DNUT is doing worse than 65.67% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-17.16%
ROE	-65.09%
ROIC	N/A

ROA(3y)-0.53%

ROA(5y)-0.89%

ROE(3y)-1.44%

ROE(5y)-3.14%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 29.14%, DNUT is doing worse than 78.36% of the companies in the same industry.

DNUT's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for DNUT so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	29.14%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.61%

GM growth 5Y0.06%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, DNUT has more shares outstanding

Compared to 5 years ago, DNUT has more shares outstanding

Compared to 1 year ago, DNUT has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.12, we must say that DNUT is in the distress zone and has some risk of bankruptcy.

DNUT has a worse Altman-Z score (0.12) than 83.58% of its industry peers.

A Debt/Equity ratio of 1.28 is on the high side and indicates that DNUT has dependencies on debt financing.

DNUT has a Debt to Equity ratio of 1.28. This is comparable to the rest of the industry: DNUT outperforms 57.46% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.28
Debt/FCF	N/A
Altman-Z	0.12

ROIC/WACCN/A

WACC8.24%

2.3 Liquidity

DNUT has a Current Ratio of 0.34. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.34, DNUT is doing worse than 86.57% of the companies in the same industry.

DNUT has a Quick Ratio of 0.34. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of DNUT (0.26) is worse than 88.81% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.34
Quick Ratio	0.26

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for DNUT have decreased strongly by -183.33% in the last year.

The Revenue for DNUT has decreased by -11.55% in the past year. This is quite bad

DNUT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.66% yearly.

EPS 1Y (TTM)-183.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-400%

Revenue 1Y (TTM)-11.55%

Revenue growth 3Y6.35%

Revenue growth 5Y11.66%

Sales Q2Q%-13.46%

3.2 Future

DNUT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -29.84% yearly.

Based on estimates for the next years, DNUT will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.

EPS Next Y-310.37%

EPS Next 2Y-75.92%

EPS Next 3Y-38.35%

EPS Next 5Y-29.84%

Revenue Next Year-8.14%

Revenue Next 2Y-2.76%

Revenue Next 3Y-0.41%

Revenue Next 5Y3.86%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DNUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DNUT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DNUT is valued a bit more expensive than 73.13% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	28.26

4.3 Compensation for Growth

A cheap valuation may be justified as DNUT's earnings are expected to decrease with -38.35% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-75.92%

EPS Next 3Y-38.35%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.93%, DNUT has a reasonable but not impressive dividend return.

DNUT's Dividend Yield is rather good when compared to the industry average which is at 4.09. DNUT pays more dividend than 88.81% of the companies in the same industry.

DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.

		Industry Rank	Sector Rank
Dividend Yield	3.93%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.

DNUT has not decreased its dividend in the last 3 years.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years3

5.3 Sustainability

The earnings of DNUT are negative and hence is the payout ratio. DNUT will probably not be able to sustain this dividend level.

DP-5.28%

EPS Next 2Y-75.92%

EPS Next 3Y-38.35%

More info and screens

Find the best dividend stocks

Show peers with best dividend

KRISPY KREME INC

NASDAQ:DNUT (9/2/2025, 8:00:01 PM)

After market: 3.35 +0.01 (+0.3%)

3.34

-0.21 (-5.92%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryHotels, Restaurants & Leisure

Earnings (Last)08-07 2025-08-07/bmo

Earnings (Next)11-05 2025-11-05/bmo

Inst Owners52.14%

Inst Owner Change-11.58%

Ins Owners3.54%

Ins Owner Change1.72%

Market Cap571.81M

Analysts71.76

Price Target5.38 (61.08%)

Short Float %28.38%

Short Ratio2.43

Dividend

		Industry Rank	Sector Rank
Dividend Yield	3.93%

Yearly Dividend0.14

Dividend Growth(5Y)N/A

DP-5.28%

Div Incr Years0

Div Non Decr Years3

Ex-Date04-23 2025-04-23 (0.035)

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-177.39%

Min EPS beat(2)-353.46%

Max EPS beat(2)-1.32%

EPS beat(4)0

Avg EPS beat(4)-159.22%

Min EPS beat(4)-353.46%

Max EPS beat(4)-1.32%

EPS beat(8)1

Avg EPS beat(8)-88.63%

EPS beat(12)4

Avg EPS beat(12)-59.14%

EPS beat(16)5

Avg EPS beat(16)-45.87%

Revenue beat(2)0

Avg Revenue beat(2)-2.92%

Min Revenue beat(2)-4.3%

Max Revenue beat(2)-1.53%

Revenue beat(4)0

Avg Revenue beat(4)-3.14%

Min Revenue beat(4)-4.66%

Max Revenue beat(4)-1.53%

Revenue beat(8)1

Avg Revenue beat(8)-2.08%

Revenue beat(12)4

Avg Revenue beat(12)-1.18%

Revenue beat(16)4

Avg Revenue beat(16)-1.25%

PT rev (1m)-8.61%

PT rev (3m)-46.97%

EPS NQ rev (1m)-45.51%

EPS NQ rev (3m)-365.77%

EPS NY rev (1m)-177.56%

EPS NY rev (3m)-201.31%

Revenue NQ rev (1m)1.05%

Revenue NQ rev (3m)-6.14%

Revenue NY rev (1m)0.13%

Revenue NY rev (3m)-2.24%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.37
P/FCF	N/A
P/OCF	N/A
P/B	0.82
P/tB	N/A
EV/EBITDA	28.26

EPS(TTM)-0.2

EYN/A

EPS(NY)-0.13

Fwd EYN/A

FCF(TTM)-0.8

FCFYN/A

OCF(TTM)-0.13

OCFYN/A

SpS8.99

BVpS4.05

TBVpS-4.85

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-17.16%
ROE	-65.09%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	29.14%
FCFM	N/A

ROA(3y)-0.53%

ROA(5y)-0.89%

ROE(3y)-1.44%

ROE(5y)-3.14%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.61%

GM growth 5Y0.06%

F-Score3

Asset Turnover0.59

Health

		Industry Rank	Sector Rank
Debt/Equity	1.28
Debt/FCF	N/A
Debt/EBITDA	16.28
Cap/Depr	84.51%
Cap/Sales	7.42%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.34
Quick Ratio	0.26
Altman-Z	0.12

F-Score3

WACC8.24%

ROIC/WACCN/A

Cap/Depr(3y)96.05%

Cap/Depr(5y)105.48%

Cap/Sales(3y)7.25%

Cap/Sales(5y)7.82%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-183.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-400%

EPS Next Y-310.37%

EPS Next 2Y-75.92%

EPS Next 3Y-38.35%

EPS Next 5Y-29.84%

Revenue 1Y (TTM)-11.55%

Revenue growth 3Y6.35%

Revenue growth 5Y11.66%

Sales Q2Q%-13.46%

Revenue Next Year-8.14%

Revenue Next 2Y-2.76%

Revenue Next 3Y-0.41%

Revenue Next 5Y3.86%

EBIT growth 1Y-745.64%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year491.36%

EBIT Next 3Y94.78%

EBIT Next 5YN/A

FCF growth 1Y-875.33%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-117.45%

OCF growth 3Y-31.28%

OCF growth 5Y-10.72%

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens